Vistin Pharma
VISTN.OL
#8709
Rank
โ‚น8.65 B
Marketcap
โ‚น195.15
Share price
0.39%
Change (1 day)
17.11%
Change (1 year)

P/E ratio for Vistin Pharma (VISTN.OL)

P/E ratio as of November 2024 (TTM): 19.3

According to Vistin Pharma's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 19.2725. At the end of 2023 the company had a P/E ratio of 22.6.

P/E ratio history for Vistin Pharma from 2016 to 2024

PE ratio at the end of each year

Year P/E ratio Change
202322.6-115.75%
2022-144-515.05%
202134.6-534.32%
2020-7.97-214.16%
20196.98-305.46%
2018-3.40-211.14%
20173.06-90.32%
201631.665.27%
201519.1

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.